CPRIT extends Company Investment application date to January 12, 2010

NewsGuard 100/100 Score

The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that it has extended the deadline to January 12, 2010 to file a letter of intent to submit a proposal for the Company Investment request for application (RFA). The RFA is available on the CPRIT website, www.cprit.state.tx.us/funding.html.

CPRIT will foster cancer research as well as product and service development in Texas by providing financial support for a wide variety of projects relevant to cancer. This investment award is intended to support companies undertaking product research and development in Texas with Texas-based employees. It will allow companies or limited partnerships located in Texas, or those that are willing to relocate to Texas, the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap.

Companies are encouraged to submit applications for innovative products addressing critically important needs related to diagnosis, prevention, and/or treatment of cancer and the product development infrastructure needed to support these efforts. The long-term objective of this investment award is to support commercially oriented translational research, therapeutic and medical technology products, diagnostic- or treatment-oriented information technology products, diagnostics, tools, services, and infrastructure projects. No maximum award amount is set on the amount of funding that can be requested.

Applicants must file a letter of intent. The company investment letter of intent will help CPRIT align its review committees with the expected applications. CPRIT began accepting letters of intent through its web-based grant portal www.cpritgrants.org on December 1, 2009 until January 12, 2010.

Company Investment applications will be accepted starting February 12, 2010 through March 1, 2010. Applications will be reviewed March – May, 2010, and award notifications are expected in June 2010.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gut microbiome study challenges established cancer biomarkers, identifies new bacterial links to colorectal cancer